Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
Cart
header search
Search
Skip Nav Destination

First Edition

Research Article August 27 2025
An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden
Erin W Meermeier,Kirsten Pfeffer,Caleb K Stein,Meaghen Sharik,Megan Tien Du,Yuliza Tafoya Alvarado,Chang-Xin Shi,Yuan Xiao Zhu,Peter Leif Bergsagel,Marta Chesi
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Review Article August 26 2025
Platelet Heterogeneity: Variety Makes Immune and Vascular Function Better
Michael Malloy,Kathleen E McGrath,Craig N Morrell
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Research Article August 26 2025
Chronic NK cell activation results in a dysfunctional, tissue resident-like state mediated by KLF2 deficiency
Jacob Myers,Rih-Sheng Huang,Shee Kwan Phung,Jeremy M. Chacón,Laura E Bendzick,Anna Jo Weis,Mihir Shetty,Taylor DePauw,Melissa J Khaw,Juan E Abrahante Llorens,Stephen D O'Flanagan,K Maude Ashby,John R Lozada,Stephen C. Jameson,Justin H Hwang,Frank Cichocki,Martin Felices,Jeffrey S. Miller
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Review Article August 26 2025
Novel Strategies Targeting Mutant Calreticulin in Essential Thrombocythemia and Myelofibrosis
Gabriel S Salzman,Ann Mullally
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Research Article August 26 2025
LEF1 Intragenic Deletion Induces a Dominant-Negative isoform and unveils a Wnt/β3-Catenin Vulnerability in T-ALL
Manon Delafoy,Mickaël Frédéric Bonnet,Etienne Lengliné,Agata Cieslak,Aurore Touzart,Estelle Balducci,Mathieu Simonin,Véronique Lheritier,Marie-Emilie Dourthe,Benoit Heid-Picard,Sylvain Latour,Hervé Dombret,Philippe Rousselot,André Baruchel,Nicolas Boissel,Guillaume P. Andrieu,Vahid Asnafi
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article August 20 2025
Factor VIIa-released extracellular vesicles attenuate joint bleed-induced hemophilic arthropathy
Padmavathi Kavadipula,Shiva Keshava,Kaushik Das,Jhansi Magisetty,Christian DeJong,Josthna Penchalaneni,Usha Pendurthi,L. Vijaya Mohan Rao
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article August 19 2025
Layilin inhibits integrin activation, and its loss results in platelet hyperactivation via Rac1 in inflammatory bowel disease
Rebecca A Mellema,Kimberly A Queisser,Abigail Ajanel,Nansy Albtoush,Lydia Smith,Matt Rondina,Julie Will,John F Valentine,Aaron C. Petrey
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Research Article August 14 2025
Cryo-EM structure of the tissue factor/factor VIIa complex with a factor X mimetic reveals a novel allosteric mechanism
Josepha C Sedzro,Amanda L. Photenhauer,Fabienne Birkle,Katarina Meze,Alex Mortenson,Cade Duckworth,Po-Chao Wen,Sarah Kearns,Michael A. Cianfrocco,Emad Tajkhorshid,Melanie D. Ohi,James H. Morrissey
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Review Article August 4 2025
How I Manage Chronic Myeloid Leukemia During Pregnancy
Elisabetta Abruzzese,Ekaterina Chelysheva
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Research Article July 25 2025
Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial
Jing Pan,Liping Zhao,Yibing Zhang,Samuel Seery,Yue Tan,Biping Deng,Lingling Shan,Zhuojun Ling,Fan Wu,Quangang Wang,Xinjian Yu,Qinlong Zheng,Xiuwen Xu,Ying Yuan,Zhenglong Tian,Yanlei Zhang,Shuixiu Peng,Alex H. H. Chang,Xiaoming Feng
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Review Article July 15 2025
The Treatment of Marginal Zone Lymphoma
Juan Pablo Alderuccio,Ariela Noy
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Research Article July 10 2025
Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane Antigens
Leonie Rieger,Kilian Irlinger,Franziska Füchsl,Marlene Tietje,Anna Purcarea,Nicolas Mathis Barbian,Melanie Faber,Carolin Vogelsang,Lisa Pfeuffer,Sonja Stotz,Oleksandra Karpiuk,Tobias Schulze,Abirami Augsburger,Nadine Glaisner,Verena Konetzki,Sabrina Friedel,Andrej Besse,Lenka Besse,Christoph Driessen,Maike Buchner,Kristina Schwamborn,Katja Steiger,Piero Giansanti,Sebastian Theurich,Johannes M. Waldschmidt,Klaus Martin Kortüm,Michael Hudecek,Hermann Einsele,Marion Högner,Bernhard Kuster,Angela Krackhardt,Judith S. Hecker,Florian Bassermann
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplementary data
Review Article May 15 2025
How I Evaluate and Treat Resistance and Relapse in CML
Simona Soverini,Fausto Castagnetti
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Review Article May 12 2025
How I approach hematopoietic stem cell transplantation for CML in a TKI world
Yves Chalandon,Federico Simonetta,Stavroula Masouridi-Levrat
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Review Article April 16 2025
How I individualize treatment for chronic-phase CML
Ariel Monet Leyte-Vidal,Neil P. Shah
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Review Article March 25 2025
How I treat chronic myeloid leukemia in children and adolescents
Jing Chen,Meinolf Suttorp,Nobuko Hijiya
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Page 3 of 3

Advertisement intended for health care professionals

How I Treat Advanced Phases of CML
NLRP3 inflammasome blockade treats intestinal inflammation associated with chronic granulomatous disease.
Proteomics: the key to understanding AML hematopoietic aging
FLI1-related thrombocytopenia: piecing together the story
Yeung DT, Shanmuganathan N, Reynolds J, et al; Australasian Leukaemia and Lymphoma Group. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study. Blood. 2024;144(19):1993-2001.

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals